---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-035433"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-29T23:32:28.784444+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BIO-key Q3 revenue up 18% to $2.1M; net loss narrows to $0.7M from $1.8M

## Summary
- Revenue $2.1M vs $1.8M; license revenue rose 52% to $1.4M on expanded customer deployments.
- Gross margin improved to 78.3% from 18.7%; net loss per share $0.39 vs $3.22 YoY.
- Cash position strengthened to $1.8M at Sep 30 from $0.5M at Dec 31, aided by $1.9M warrant inducement.
- Recent orders: $910k from financial services customer, $500k from defense ministry; 10,000 users added by British Columbia.
- Full-year 2024 revenue expected to meet or exceed $7.75M achieved in 2023.

## SEC filing metadata
- accession: 0001437749-24-035433
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774924035433/0001437749-24-035433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774924035433/bkyi20241114_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-035433
- JSON: https://secwatch.observer/filing/0001437749-24-035433.json
- Plain text: https://secwatch.observer/filing/0001437749-24-035433.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.